曲伐沙星（CP-99,219）、司帕沙星、环丙沙星和氟罗沙星对呼吸道病原体的体外活性。 - Suppr

Suppr

超能文献

In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens.

作者信息

Crokaert F, Aoun M, Duchateau V, Grenier P, Vandermies A, Klastersky J

机构信息

Institut Jules Bordet, Internal, University of Brussels, Belgium.

出版信息

Eur J Clin Microbiol Infect Dis. 1996 Aug;15(8):696-8. doi: 10.1007/BF01691164.

DOI:10.1007/BF01691164

PMID:8894585

Abstract

摘要

相似文献

In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens.曲伐沙星（CP-99,219）、司帕沙星、环丙沙星和氟罗沙星对呼吸道病原体的体外活性。

Eur J Clin Microbiol Infect Dis. 1996 Aug;15(8):696-8. doi: 10.1007/BF01691164.

[In vitro activity of trovafloxacin in 238 respiratory pathogens].[曲伐沙星对238种呼吸道病原体的体外活性]

Rev Esp Quimioter. 1998 Mar;11(1):47-51.

Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens.莫西沙星及其他喹诺酮类药物针对社区获得性呼吸道病原体的体外评价多中心研究

Int J Antimicrob Agents. 2001 Oct;18(4):379-82. doi: 10.1016/s0924-8579(01)00419-8.

Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin.

J Antimicrob Chemother. 1997 Mar;39(3):411-4. doi: 10.1093/jac/39.3.411.

Moxifloxacin sensitivity of respiratory pathogens in the United Kingdom.

J Chemother. 2002 Feb;14(1):19-24. doi: 10.1179/joc.2002.14.1.19.

Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project.吉米沙星对在亚历山大项目中分离出的欧洲呼吸道病原体的体外比较效力

J Antimicrob Chemother. 2000 Jul;46 Suppl T1:11-5. doi: 10.1093/oxfordjournals.jac.a020888.

Comparative in-vitro activity of CP-99219, a new quinolone, against respiratory pathogens.

J Antimicrob Chemother. 1996 Apr;37(4):803-8. doi: 10.1093/jac/37.4.803.

Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.欧洲呼吸道分离株对曲伐沙星、环丙沙星、克拉霉素、阿奇霉素和氨苄西林的敏感性。

Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):413-9. doi: 10.1007/BF01691574.

In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.环丙沙星、左氧氟沙星、洛美沙星、氧氟沙星、培氟沙星、司帕沙星和曲伐沙星对呼吸道感染革兰氏阳性和革兰氏阴性病原体的体外活性。

J Antimicrob Chemother. 1997 Sep;40(3):427-31. doi: 10.1093/jac/40.3.427.

Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens.新型喹诺酮类药物吉米沙星（SB - 265805）与其他氟喹诺酮类药物对呼吸道病原体的体外活性比较

J Antimicrob Chemother. 2001 May;47(5):681-4. doi: 10.1093/jac/47.5.681.

引用本文的文献

The new fluoroquinolones: A critical review.新型氟喹诺酮类药物：批判性综述。

Can J Infect Dis. 1999 May;10(3):207-38. doi: 10.1155/1999/378394.

Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.慢性支气管炎急性加重期的治疗：曲伐沙星与阿莫西林在一项多中心、双盲、双模拟研究中的比较。曲伐沙星支气管炎研究组

Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):441-6. doi: 10.1007/BF01691580.

An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin.一项关于西咪替丁对曲伐沙星稳态药代动力学影响的开放性、对照、交叉研究。

Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):431-3. doi: 10.1007/BF01691578.

Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens.新型喹诺酮类药物曲伐沙星对呼吸道病原体的细菌学活性。

Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):405-12. doi: 10.1007/BF01691573.

In vitro activity of trovafloxacin against Chlamydia pneumoniae.曲伐沙星对肺炎衣原体的体外活性。

Antimicrob Agents Chemother. 1997 Sep;41(9):2033-4. doi: 10.1128/AAC.41.9.2033.

本文引用的文献

Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).曲伐沙星（CP-99,219）的药代动力学及在炎性液中的渗透情况

Antimicrob Agents Chemother. 1996 Jan;40(1):47-9. doi: 10.1128/AAC.40.1.47.

In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.曲伐沙星（CP-99,219）的体内疗效，一种对革兰氏阳性病原体、肺炎链球菌和脆弱拟杆菌具有广泛活性的新型喹诺酮类药物。

Antimicrob Agents Chemother. 1995 Oct;39(10):2210-6. doi: 10.1128/AAC.39.10.2210.

Lower respiratory tract infection therapy--the role of ciprofloxacin.

J Int Med Res. 1995 Sep-Oct;23(5):315-27. doi: 10.1177/030006059502300501.

New quinolones and gram-positive bacteria.新型喹诺酮类药物与革兰氏阳性菌

Antimicrob Agents Chemother. 1994 Feb;38(2):163-9. doi: 10.1128/AAC.38.2.163.

In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.新型喹诺酮类药物OPC - 17116、氧氟沙星及司帕沙星对肺炎衣原体的体外活性

Antimicrob Agents Chemother. 1994 Jun;38(6):1402-3. doi: 10.1128/AAC.38.6.1402.

In vitro activity of the new fluoroquinolone CP-99,219.新型氟喹诺酮CP-99,219的体外活性

Antimicrob Agents Chemother. 1994 Nov;38(11):2615-22. doi: 10.1128/AAC.38.11.2615.

Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.新型氟喹诺酮类药物CP-99,219治疗实验性耐青霉素和头孢菌素肺炎球菌性脑膜炎的评估

Antimicrob Agents Chemother. 1995 Jun;39(6):1243-6. doi: 10.1128/AAC.39.6.1243.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验